Great post.
"My guess is that the NIH's voice will be VERY, VERY loud in the FDA's ears, much louder than MSB's or Novartis' could ever be."
I hope you are right on this one. I have my doubts though after the way the FDA treated the GVHD submission after the 9-1 yes vote from the expert panel.
My guess is that private enterprise has great influence on FDA decisions, just as it does in politics. I want Novartis by our side the whole way through.
"...when asked about an EUA for Rem-L in ARDS, SI was VERY muted."
I picked up on this too. They seemed very careful not to say anything that could even remotely influence investors decisions...they were almost underselling the significance of these results.
Great post."My guess is that the NIH's voice will be VERY, VERY...
-
- There are more pages in this discussion • 1,470 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |